About: Applied Genetic Technologies Corporation

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Applied Genetic Technologies Corporation Goto Sponge NotDistinct Permalink

An Entity of Type : dbo:Organisation, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FApplied_Genetic_Technologies_Corporation&invfp=IFP_OFF&sas=SAME_AS_OFF

The Applied Genetic Technologies Corporation is a publicly traded (Nasdaq: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. In late June 2019, the company announced the appointment of Global Clinical and Medical Affairs Veteran, Theresa G.H. Heah, M.D., M.B.A., to Join as Chief Medical Officer.

Attributes	Values
rdf:type	Thing company schema:Organization dul:Agent dul:SocialPerson agent wikidata:Q24229398 Organization Business enterprise organisation
rdfs:label	Applied Genetic Technologies Corporation (en)
rdfs:comment	The Applied Genetic Technologies Corporation is a publicly traded (Nasdaq: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. In late June 2019, the company announced the appointment of Global Clinical and Medical Affairs Veteran, Theresa G.H. Heah, M.D., M.B.A., to Join as Chief Medical Officer. (en)
foaf:name	Applied Genetic Technologies Corporation (en)
foaf:homepage	https://www.agtc.com/%7CAGTC.com
name	AGTC (en) Applied Genetic Technologies Corporation (en)
foaf:depiction
sec cik	AGTC (en)
location	Alachua, Florida
dcterms:subject	Companies listed on the Nasdaq Ophthalmology organizations 1999 establishments in Florida Biotechnology companies established in 1999
Wikipage page ID	49000778 (xsd:integer)
Wikipage revision ID	1094796471 (xsd:integer)
Link from a Wikipage to another Wikipage	Age-related macular degeneration Public company Companies listed on the Nasdaq Gene therapy NASDAQ Biotechnology Index Russell Microcap Index Optogenetics Achromatopsia Alachua, Florida Ophthalmology organizations 1999 establishments in Florida Biotechnology companies established in 1999 Biotechnology Retinitis pigmentosa Retinitis Retinoschisis Dose-escalation study
Link from a Wikipage to an external page	http://www.agtc.com/ https://www.agtc.com/%7CAGTC.com
sameAs	Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Cleanup-PR dbt:Decrease dbt:Infobox_company dbt:Multiple_issues dbt:Notability dbt:Reflist dbt:Short_description dbt:Small dbt:Start_date_and_age dbt:Ubl dbt:Finance_links dbt:US-company-stub
thumbnail	wiki-commons:Special:FilePath/Applied_Genetic_Technologies_Corporation_logo.png?width=300
bloomberg	AGTC:US (en)
google	AGTC (en)
yahoo	AGTC (en)
founded	1999-01-19 (xsd:date)
industry	Biotechnology
location	Alachua, Florida, United States (en)
logo	File:Applied Genetic Technologies Corporation logo.png (en)
symbol	AGTC (en)
traded as	Russell Microcap Index component (en) NASDAQ:AGTC (en)
type	Public company
website	https://www.agtc.com/%7CAGTC.com
has abstract	The Applied Genetic Technologies Corporation is a publicly traded (Nasdaq: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. In late June 2019, the company announced the appointment of Global Clinical and Medical Affairs Veteran, Theresa G.H. Heah, M.D., M.B.A., to Join as Chief Medical Officer. The company focuses on ophthalmologic genetic diseases. The company's technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis, X-linked retinitis pigmentosa, and age-related macular degeneration. The company has six products in various stages of development; as of 2016, none had yet been approved. In January 2017, AGTC entered into a strategic research and development collaboration with Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding. Through the collaboration, AGTC and Bionic Sight will to develop a new optogenetic therapy that leverages AGTC's deep experience in gene therapy and ophthalmology. On January 9, 2020, the company reported positive results from a Phase 1/2 trial for its investigational gene therapy for retinitis pigmentosa. A few weeks later, the company reported interim six-month data from the dose-escalation cohorts of its ongoing Phase 1/2 clinical programs in patients with achromatopsia due to mutation in the ACHM CNGB3 or ACHM CNGA3 genes. Applied Genetic Technologies Corporation is a patient partner within the blinding eye disease and rare disease community, including organizations like Foundation for Fighting Blindness and Global Genes. (en)
gold:hypernym	Part
prov:wasDerivedFrom	wikipedia-en:Applied_Genetic_Technologies_Corporation?oldid=1094796471&ns=0
page length (characters) of wiki page	7082 (xsd:nonNegativeInteger)
founding date	1999-01-19 (xsd:date)
founding year	1999-01-01 (xsd:gYear)
country	United States
industry	Biotechnology
type	Public company
foaf:isPrimaryTopicOf	wikipedia-en:Applied_Genetic_Technologies_Corporation
is Link from a Wikipage to another Wikipage of	List of Williams College people Sid Martin Biotechnology Incubator Yu Dechao
is foaf:primaryTopic of	wikipedia-en:Applied_Genetic_Technologies_Corporation

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software